Back
Status filter :


RESET SEARCH AND FILTERS
Nose
Nose / Nasal congestion
  ephedrine hydrochloride On Formulary
  pseudoephedrine hydrochloride On Formulary
  xylometazoline hydrochloride On Formulary
  Spray
Otrivine (Haleon UK Ltd) On Formulary
Nose / Nasal infection
  betamethasone with neomycin On Formulary
  chlorhexidine with neomycin On Formulary
  mupirocin On Formulary
  Nasal ointment
Bactroban (GlaxoSmithKline UK Ltd) On Formulary
Nose / Nasal inflammation, nasal polyps and rhinitis
  azelastine hydrochloride On Formulary
  beclometasone dipropionate On Formulary
  Spray
Beclometasone dipropionate (Non-proprietary) On Formulary
Beconase (GlaxoSmithKline UK Ltd, Omega Pharma Ltd) On Formulary
Nasobec (Teva UK Ltd) On Formulary
  betamethasone On Formulary
Betesil Medicated Plaster - Inflammatory Skin Disorders (November 2022)

Approved at NEL FPG (Nov 2022)

Betesil® 2.250mg medicated plaster is the only potent corticosteroid indicated in adults for the treatment of inflammatory skin disorders.

The plaster is licensed to use for a maximum of 30 days at a time, with a maximum of 6 plasters being used at any one time. Plasters may be changed once every 24 hours.

Amber-may be prescribed by or on the advice of a specialist 

  budesonide On Formulary NICE TA708
Budesonide orodispersible tablets

Budesonide orodispersible tablet for inducing remission of eosinophilic oesophagitis as per NICE TA708

Approved as Hospital Only. September 2021 DTC.

  desloratadine Off Formulary
  fexofenadine hydrochloride On Formulary
  fluticasone On Formulary
  Spray
Fluticasone (Non-proprietary) On Formulary
Allergic Rhinitis Pathway

Allergic Rhinitis Pathway

FLUTICASONE PROPIONATE

Moderate to severe symptoms of allergic rhinitis-refer to treatment algorithm for further details

  fluticasone with azelastine On Formulary
  ipratropium bromide On Formulary
  ketotifen Off Formulary
  mometasone furoate On Formulary
  rupatadine Off Formulary
  triamcinolone acetonide On Formulary